D11 Improving outcomes through novel technologies - Let's innovate together!
Wednesday 31 August 2016
Hilton Buenos Aires : Pacifico B, 3 hours
Organised by the FIP Industrial Pharmacy Section
Health care providers across the globe are developing, diagnosing, prescribing and administering medicines. However, for many patients optimal outcomes are not achieved. Achieving sustainable and affordable health is a combination of a wide variety of aspects, and many areas still have room for improvement. In this session, participants will be given some food for thought through examples of how innovations in drug development education tools, innovative information channels and receiver-tailored content, and innovations to improve adherence to treatment, may play a significant role in improving outcomes. After four introductory presentations from different parts of the health care chain participants will be divided into different groups and asked to discuss the examples and explore what other innovative approaches there could be. Participants will also be encouraged to share experiences based on their country of origin. After the breakout session each group will shortly report on the outcomes of the discussion, maximising engagement and fruitful exchange of ideas and practices.
At the conclusion of this application-based session, participants will be able to:
- Contrast different approaches on how to improve outcomes
- Analyse the gaps for achieving good outcomes
- Advocate different innovations and share experiences on how health outcomes can be improved
- Demonstrate how something new and “out of the box” could lead to better outcomes in health care.
Sini Eskola (FIP IPS, Belgium)
1) Keynote lecture: Outcomes driven health care – How to best achieve it?
Pär Tellner (EFPIA, Belgium)
2) Tailoring education to local needs — How to fill training gaps in a sustainable and affordable way? Focus on utilisation of electronic portals/e-learning
Kerstin Neumann (Apotheke Adhoc, Germany)
3) Health literacy: What are new ways to deliver information to the patient? Focus on clinical trials and new European approaches by industry and regulators
Sini Eskola (European Federation of Pharmaceutical Industries and Associations – EFPIA, Belgium)
[15:50 – 16:10 Coffee/tea break]
4) New ways to improve patient adherence — Focus on cancer care
Marlene Claycomb (Oncology UPMC Pittsburgh, USA)
5) 16:30-17:00 Interactive Discussion
Participants of this session are asked to join the table of their interest to discuss further how innovation from different angles could improve outcomes in health care. I'm suggesting that we will be moderating the groups in the following manner:
Table 1) Innovation in research and development (Pär)
- This table should be joined by the ones interested in discussing what kind of innovations in drug development (industrial pharmacists in R&D) could possibly lead to improved outcomes.
Table 2) Innovation in education (Kerstin)
- This table should be joined by the ones interested in discussing what kind of innovations in education (pharmacists and other health care professionals) could possibly lead to improved outcomes.
Table 3) Innovation in patient information (Sini)
- This table should be joined by the ones interested in discussing what kind of innovations in delivering patient information (medical information/regulatory affairs/commercial) could possibly lead to improved outcomes.
Table 4) Innovation in pharmacy/hospital pharmacy practice (Marlene)
- This table should be joined by the ones interested in discussing what kind of innovations in practice (either in community or hospital pharmacy setting) could possibly lead to improved outcome